What else has Old Norse brought us? Learn which words trace back to Old Norse here. Many of the customs of the feast of yule influenced the ways that Christmas is celebrated, such as the tradition of burning a yule log at Christmastime. Fun fact: the word jolly may have derived from the same Old Norse root that brought us yule. Geōl is related to the Old Norse jōl, the name of the Pagan winter feast lasting 12 days. Geōl means “Christmas day” or “ Christmastide” (a word for the period from Christmas Eve to related feast days in early January). What are the older names for December?īefore December entered Old English, the names Ǣrra Gēola or Gēolmōnað, meaning “yule month,” were used. The early Germanic people referred to this wintry season as yuletide, a two-month period that spanned December and January. But, by the time the Julian calendar was established in 45 BCE, January and February appeared at the beginning of the year, which bumped all of the original months (and their originally assigned names) back by two. January and February were eventually added after December to the end of the year. All rights reserved.Why? Well, the ancient Roman calendar only had ten months in the year, beginning with the month of March. The CNS efficacy of these compounds in anticonvulsant animal models as well as other disease model systems are presented in Tables 1 and 2 and their proposed mechanism of action at summarized in Table 3.Ĭopyright © 2010 Elsevier B.V. Since the previous Eilat Conference (EILAT IX-2008) two new AEDs eslicarbazepine acetate and lacosamide have been marketed and three new AEDs in development not included in the EILAT IX manuscript were added: ICA-105665, perampanel and valnoctamide. These include brivaracetam, carisbamate, 2-deoxy-glucose, ganaxolone, huperizine A, ICA-105665, NAX-5055, retigabine, perampanel, T-2007, valnoctamide and YK3089. Like the previous EILAT (EILAT IX) manuscript, the current (EILAT X) manuscript focuses only on the preclinical and clinical pharmacology of AEDs that are currently in development. Consistent with previous formats of this conference, a large part of the program was devoted to a review of AEDs in development, as well as updates on AEDs introduced since 1994.

About 200 basic scientists, clinical pharmacologists and neurologists from 25 countries attended the conference, whose main themes included learning from the past: Lessons learnt after 18 years of Eilat Conferences and Detecting assessing and preventing adverse effects of AEDs.

The Tenth Eilat Conference on New Antiepileptic Drugs (AEDs)-EILAT X, took place in Eilat, Israel from the 25th to 29th of April 2010.

Tenth of dec